Phase II Clinical and Pharmacokinetic Study of Plitidepsin 3-Hour Infusion Every Two Weeks Alone or with Dexamethasone in Relapsed and Refractory Multiple Myeloma

M. V. Mateos, M. T. Cibeira, P. G. Richardson, F. Prosper, A. Oriol, J. de la Rubia, J. J. Lahuerta, R. Garcia-Sanz, S. Extremera, S. Szyldergemajn, C. Corrado, H. Singer, C. S. Mitsiades, K. C. Anderson, J. Blade, J. San Miguel
  • Clinical Cancer Research, June 2010, American Association for Cancer Research (AACR)
  • DOI: 10.1158/1078-0432.ccr-10-0469
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Albert Oriol